Hsa-miR-21 promoted the progression of lung adenocarcinoma by regulating LRIG1 expression
Abstract Lung cancer is the foremost cause of cancer-related fatalities globally, and lung adenocarcinoma (LUAD) is one of the common types of lung cancer with significant molecular heterogeneity. Leucine rich repeats and immunoglobulin like domains 1 (LRIG1) has been demonstrated to be down-regulat...
Saved in:
| Main Authors: | Li Liu, Xinhua Liu, Chengpeng Gao, Meijuan Liu, Mengmeng Peng, Leqiang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-025-03620-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations
by: Feiying Meng
Published: (2021-06-01) -
Metformin modulates FJX1 via upregulation of Hsa-miR-1306-3p to suppress colon adenocarcinoma viability
by: Jung-min Kim, et al.
Published: (2025-02-01) -
Evaluation of LRIG1 Expression in Larynx Pathologies
by: Yavuz Gündoğdu, et al.
Published: (2022-06-01) -
The impact of hsa-miR-1972 on the expression of von Willebrand factor in breast cancer progression regulation
by: Changjiang Yu, et al.
Published: (2024-11-01) -
Hsa-miR-21-5p is induced by interleukin-6 and affects multiple pathogenic factors associated with fibroblast-like synoviocytes in rheumatoid arthritis
by: Kei Araki, et al.
Published: (2025-06-01)